Your Messages Inbox
Your Article Summary
See Latest Articles(Click the title below to leave the MDLinx Network and go to the Journal's Website)
Drug safety concern damages Novartis sales
Corporate News Releases - The Healthcare Sales & Marketing Network, 07/18/07
Swiss drug company Novartis has lowered its full-year sales outlook owing to the withdrawal of Zelnorm, its gastrointestinal drug, generic competition for other medicines in the US and delays in new products. Zelnorm, a drug to combat irritable bowel syndrome, was withdrawn in the US at the end of March following cardiovascular safety concerns
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Go Go Generics
PharmExec, 12/18/09
MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09
Almirall and Forest Laboratories to Expand Respiratory Collaboration with LAS100977
Forest Laboratories, 12/18/09
Article Search
Sponsor